Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

bardoxolone methyl

The methyl ester form of bardoxolone, a synthetic triterpenoid compound with potential antineoplastic and anti-inflammatory activities. Bardoxolone blocks the synthesis of inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2), two enzymes involved in inflammation and carcinogenesis. This agent also inhibits the interleukin-1 (IL-1)-induced expression of the pro-inflammatory proteins matrix metalloproteinase-1 (MMP-1) and matrix metalloproteinase-13 (MMP-13) and the expression of Bcl-3; Bcl-3 is an IL-1-responsive gene that preferentially contributes to MMP-1 gene expression.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:CDDO methyl ester
CDDO-Me
Code name:RTA 402
Chemical structure:(+)-methyl 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oate
2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid methyl ester
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search